tiprankstipranks
Trending News
More News >
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market
Advertisement

Verona Pharma (VRNA) Technical Analysis

Compare
862 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is 1.01, suggesting Verona Pharma Plc is a Buy.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 105.28, while Verona Pharma Plc’s (VRNA) share price is $106.1, making it a Buy.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 100.59, while Verona Pharma Plc’s (VRNA) share price is $106.1, making it a Buy.

Verona Pharma (VRNA) Pivot Points

Sep 04, 2025, 08:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
105.48
105.60
105.75
105.87
106.02
106.14
106.29
Fibonacci
105.60
105.70
105.76
105.87
105.97
106.03
106.14
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Sep 04, 2025, 08:51 AM
Period
Simple
Exponential
MA5
105.87Buy
105.90Buy
MA10
105.73Buy
105.75Buy
MA20
105.54Buy
105.28Buy
MA50
102.55Buy
100.59Buy
MA100
88.07Buy
90.50Buy
MA200
70.56Buy
72.60Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 105.75, while Verona Pharma Plc’s (VRNA) share price is $106.1, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 90.50, while Verona Pharma Plc’s (VRNA) share price is $106.1, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $106.1 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 102.55, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $106.1 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 88.07, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $106.1 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 70.56, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Sep 04, 2025, 08:51 AM
Name
Value
Implied Action
RSI (14)
70.59
Sell
STOCH (9,6)
93.85
Sell
STOCHRSI (14)
94.16
Sell
MACD (12,26)
1.01
Buy
ADX (14)
35.58
Neutral
Williams %R
-3.19
Sell
CCI (14)
152.77
Sell
ATR (14)
0.52
-
Ultimate Oscillator
65.93
Neutral
ROC
0.87
Buy
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 70.59, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 35.58, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is 152.77, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is 0.87, creating a Buy signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 70.59, which suggests VRNA is a Sell.
      What is VRNA’s MACD?
      VRNA’s MACD is 1.01, which suggests VRNA is a Buy.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 105.87, which suggests VRNA is a Buy.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 105.54, which suggests VRNA is a Buy.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 102.55, which suggests VRNA is a Buy.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 70.56, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -3.19, which suggests VRNA is a Sell.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is 152.77, which suggests VRNA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis